ABVC BioPharma, Inc. - Common Stock (ABVC)
1.1050
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 6:09 AM EDT
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · April 1, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · March 31, 2025

ABVC BioPharma just reported results for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

ABVC BioPharma just reported results for the first quarter of 2024.
Via InvestorPlace · May 17, 2024

These stocks have an unusual volume in today's session
Via Chartmill · February 24, 2025

On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill · February 21, 2025

Via Benzinga · October 29, 2024

Via Benzinga · October 16, 2024

Via Benzinga · October 15, 2024

Via Benzinga · April 24, 2024

Via Benzinga · April 23, 2024

Via Benzinga · April 10, 2024

Via Benzinga · April 1, 2024

ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply, and distribution rights.
Via Benzinga · March 26, 2024

Via Benzinga · March 26, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via Benzinga · January 4, 2024

Via Benzinga · January 4, 2024

Via Benzinga · January 4, 2024

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.
Via Benzinga · January 4, 2024

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Via InvestorPlace · January 4, 2024

Via Benzinga · January 3, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.
Via Benzinga · January 3, 2024

Via Benzinga · January 3, 2024